PT82650B - Processo para a preparacao de espiro-imidazolidinas uteis como inibidores da aldose-reductase - Google Patents

Processo para a preparacao de espiro-imidazolidinas uteis como inibidores da aldose-reductase

Info

Publication number
PT82650B
PT82650B PT82650A PT8265086A PT82650B PT 82650 B PT82650 B PT 82650B PT 82650 A PT82650 A PT 82650A PT 8265086 A PT8265086 A PT 8265086A PT 82650 B PT82650 B PT 82650B
Authority
PT
Portugal
Prior art keywords
imidazolidines
uwhumph
aldose
preparation
reductase inhibitors
Prior art date
Application number
PT82650A
Other languages
English (en)
Other versions
PT82650A (en
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT82650A publication Critical patent/PT82650A/pt
Publication of PT82650B publication Critical patent/PT82650B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
PT82650A 1985-05-29 1986-05-27 Processo para a preparacao de espiro-imidazolidinas uteis como inibidores da aldose-reductase PT82650B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/738,924 US4575507A (en) 1985-05-29 1985-05-29 Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

Publications (2)

Publication Number Publication Date
PT82650A PT82650A (en) 1986-06-01
PT82650B true PT82650B (pt) 1988-11-30

Family

ID=24970055

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82650A PT82650B (pt) 1985-05-29 1986-05-27 Processo para a preparacao de espiro-imidazolidinas uteis como inibidores da aldose-reductase

Country Status (21)

Country Link
US (1) US4575507A (pt)
EP (1) EP0203791B1 (pt)
JP (1) JPS61277671A (pt)
KR (1) KR890001548B1 (pt)
AT (1) ATE46332T1 (pt)
AU (1) AU560429B2 (pt)
DD (5) DD264214A5 (pt)
DE (1) DE3665584D1 (pt)
DK (1) DK248886A (pt)
EG (1) EG17859A (pt)
ES (2) ES8800228A1 (pt)
FI (1) FI862251A (pt)
GR (1) GR861388B (pt)
HU (4) HU199845B (pt)
IL (1) IL78954A (pt)
NO (1) NO862123L (pt)
NZ (1) NZ216334A (pt)
PH (1) PH22213A (pt)
PL (5) PL146020B1 (pt)
PT (1) PT82650B (pt)
ZA (1) ZA863934B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198212B (en) * 1984-07-20 1989-08-28 Pfizer Process for production of spiro-imidasolones
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
EP0306525A4 (en) * 1987-03-20 1991-04-24 Alcon Laboratories Inc Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
AU623676B2 (en) * 1988-08-24 1992-05-21 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US8326636B2 (en) * 2008-01-16 2012-12-04 Canyon Ip Holdings Llc Using a physical phenomenon detector to control operation of a speech recognition engine
WO2013117568A1 (de) * 2012-02-09 2013-08-15 Boehringer Ingelheim International Gmbh Verfahren zur stereoselektiven synthese von 1,4-geschützten 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
DE3367103D1 (en) * 1982-11-10 1986-11-27 Pfizer Sorbinil by optical resolution with aminopinane derivatives
SU1380610A3 (ru) * 1982-12-06 1988-03-07 Пфайзер Инк. (Фирма) Способ получени спирогетероазолидиндионов или их фармацевтически приемлемых солей
US4556670A (en) 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
EP0159143B1 (en) * 1984-03-23 1987-12-16 Pfizer Inc. Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4762838A (en) 1985-08-30 1988-08-09 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents

Also Published As

Publication number Publication date
NZ216334A (en) 1988-08-30
PL266364A1 (en) 1988-03-03
PL146020B1 (en) 1988-12-31
HU199845B (en) 1990-03-28
HUT49882A (en) 1989-11-28
GR861388B (en) 1986-09-17
HUT44767A (en) 1988-04-28
PL266366A1 (en) 1988-03-03
PL266365A1 (en) 1988-03-03
PL147398B1 (en) 1989-05-31
ZA863934B (en) 1988-01-27
DE3665584D1 (de) 1989-10-19
DK248886D0 (da) 1986-05-28
PH22213A (en) 1988-06-28
FI862251A0 (fi) 1986-05-28
PL147399B1 (en) 1989-05-31
DD264214A5 (de) 1989-01-25
ES555375A0 (es) 1987-11-01
ATE46332T1 (de) 1989-09-15
JPS61277671A (ja) 1986-12-08
FI862251A (fi) 1986-11-30
EP0203791B1 (en) 1989-09-13
HU196060B (en) 1988-09-28
US4575507A (en) 1986-03-11
EG17859A (en) 1991-11-30
DD273258A5 (de) 1989-11-08
IL78954A (en) 1989-09-28
IL78954A0 (en) 1986-09-30
HUT49879A (en) 1989-11-28
DK248886A (da) 1986-11-30
EP0203791A1 (en) 1986-12-03
PT82650A (en) 1986-06-01
DD264215A5 (de) 1989-01-25
PL147397B1 (en) 1989-05-31
ES557391A0 (es) 1988-02-16
HU893127D0 (en) 1990-01-28
ES8801830A1 (es) 1988-02-16
PL147400B1 (en) 1989-05-31
ES8800228A1 (es) 1987-11-01
NO862123L (no) 1986-12-01
PL266363A1 (en) 1988-03-03
AU560429B2 (en) 1987-04-09
AU5801286A (en) 1987-01-08
DD264213A5 (de) 1989-01-25
DD251972A5 (de) 1987-12-02
KR860008984A (ko) 1986-12-19
KR890001548B1 (en) 1989-05-08

Similar Documents

Publication Publication Date Title
DE3688377D1 (de) Verfahren zur verbesserung des gedaechnisses oder zur beseitigung des gedaechnis-mangels mit arylamido-(und arylthioamido)-azabicycloalkanen.
ZA867988B (en) Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzene-acetic acids,salts and esters
ES2115163T3 (es) Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis.
DK0632036T3 (da) Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser
ES556748A0 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxolicas.
PT82650B (pt) Processo para a preparacao de espiro-imidazolidinas uteis como inibidores da aldose-reductase
PT84157B (pt) Processo para a preparacao de imuno-estimulantes de heptanoil-glu-asp-amino-acidos
DE68926418T2 (de) S'-adenosyl-methionin-decarboxylase-Inhibitoren
DK0446921T3 (da) Optisk aktive alkylendioxybenzenderivater og deres anvendelse ved terapi
DE69504392T2 (de) Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen
ES508415A0 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
ATE109454T1 (de) Catecholaminester.
ES8506691A1 (es) Procedimiento para la obtencion de derivados de la ditiol-1,2 ona-3

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19921031